Brooklyn Immunotherapeutics Buy Hold or Sell Recommendation
| BTXDelisted Stock | USD 0.21 0.01 5.00% |
Considering the 90-day investment horizon and your conservative attitude towards risk, our recommendation regarding Brooklyn Immunotherapeutics is 'Not Rated'. Macroaxis provides Brooklyn Immunotherapeuti buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BTX positions. The advice algorithm takes into account all of Brooklyn Immunotherapeuti's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Brooklyn Immunotherapeuti's buy or sell advice are summarized below:
Real Value 0.2 | Hype Value 0.21 | Market Value 0.21 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Brooklyn Immunotherapeutics given historical horizon and risk tolerance towards Brooklyn Immunotherapeuti. When Macroaxis issues a 'buy' or 'sell' recommendation for Brooklyn Immunotherapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Brooklyn |
Execute Brooklyn Immunotherapeuti Buy or Sell Advice
The Brooklyn recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Brooklyn Immunotherapeutics. Macroaxis does not own or have any residual interests in Brooklyn Immunotherapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Brooklyn Immunotherapeuti's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Brooklyn Immunotherapeuti Trading Alerts and Improvement Suggestions
| Brooklyn Immunotherapeuti is not yet fully synchronised with the market data | |
| Brooklyn Immunotherapeuti has some characteristics of a very speculative penny stock | |
| Brooklyn Immunotherapeuti has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 3.45 M. Reported Net Loss for the year was (106.73 M) with profit before taxes, overhead, and interest of 4.69 M. | |
| Brooklyn Immunotherapeutics has about 19.41 M in cash with (22.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.33, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 42.0% of the company shares are held by company insiders |
Brooklyn Immunotherapeuti current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Brooklyn analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Brooklyn analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Mean Price | 3.00 | |
| Target Median Price | 3.00 | |
| Target High Price | 3.00 | |
| Recommendation Mean | 3.00 | |
| Number Of Analyst Opinions | 1 | |
| Target Low Price | 3.00 |
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Brooklyn Immunotherapeuti Returns Distribution Density
The distribution of Brooklyn Immunotherapeuti's historical returns is an attempt to chart the uncertainty of Brooklyn Immunotherapeuti's future price movements. The chart of the probability distribution of Brooklyn Immunotherapeuti daily returns describes the distribution of returns around its average expected value. We use Brooklyn Immunotherapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Brooklyn Immunotherapeuti returns is essential to provide solid investment advice for Brooklyn Immunotherapeuti.
| Mean Return | -1.46 | Value At Risk | -8.82 | Potential Upside | 6.12 | Standard Deviation | 4.93 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Brooklyn Immunotherapeuti historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Brooklyn Immunotherapeuti Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Brooklyn . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Brooklyn Immunotherapeuti Buy or Sell Advice
When is the right time to buy or sell Brooklyn Immunotherapeutics? Buying financial instruments such as Brooklyn Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Brooklyn Immunotherapeuti in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Blend Funds Thematic Idea Now
Large Blend Funds
Fund or Etfs that invest in stocks of large organizations that have characteristics of both growth and value companies. The Large Blend Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Blend Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Brooklyn Stock
If you are still planning to invest in Brooklyn Immunotherapeuti check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Brooklyn Immunotherapeuti's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |